Neoadjuvant Immunotherapy and De-escalation of Surgery in Locally Advanced Breast Implant-associated Anaplastic Large Cell Lymphoma
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare form of non-Hodgkin T-cell lymphoma diagnosed in patients with a history of breast implants. Most patients develop a periprosthetic effusion at early stages of disease while less common presentations include a palpable mas...
Saved in:
Main Authors: | Marzia Salgarello, Jaroslaw Krupa, Rebecca Allchin, Simon Pilgrim, Fiona Miall, Arianna Di Napoli, Maurizio Martelli, Giulio Tarantino |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical Publishers, Inc.
2025-01-01
|
Series: | Archives of Plastic Surgery |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-2427-2066 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Features of Differential Diagnosis of Breast Implant Rupture and Breast Implant-Associated Anaplastic Large Cell Lymphoma
by: A. A. Nekrasov, et al.
Published: (2020-06-01) -
SYSTEMATIC REVIEW: ANAPLASTIC LARGE CELL LYMPHOMA FOLLOWING BREAST IMPLANT SURGERY
by: Kezia Eveline, et al.
Published: (2023-06-01) -
Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study
by: Zhiqiang Zhao, et al.
Published: (2025-01-01) -
Comparison of outcomes following prepectoral and subpectoral implants for breast reconstruction in patients with breast cancer
by: Jun Zhang, et al.
Published: (2025-01-01) -
Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)